Catherine C. Park, MD

University of California, Berkeley, CA, B.A., 1989, History of Art
UCLA School of Medicine, Los Angeles, CA, M.D., 1995, Medicine
Beth Israel Hospital, Harvard Medical School, Boston, MA, 1996, Internship, Internal Medicine
Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA, 2000, Residency, Radiation Oncology

• 1998-1999
  Research Associate, Lawrence Berkeley National Laboratory, Berkeley, CA
• 2000-2006
  Visiting Scientist, Lawrence Berkeley National Laboratory, Berkeley, CA
• 2006-present
  Faculty Biologist, Lawrence Berkeley National Laboratory, Berkeley, CA
• 2000-2008
  Assistant Professor, UCSF, Department of Radiation Oncology
• 2008-present
  Associate Professor, UC San Francisco, Department of Radiation Oncology, San Francisco, CA
• 2009
  Faculty Member, UCSF Institute for Molecular Medicine, San Francisco, CA

• 1994
  Alpha Omega Alpha
• 1995
  AMWA Janet M. Glascow Memorial Achievement Citation
• 1995
  C. Donald O'Malley Prize in the History of Medicine
• 1995
  Dean's Scholar, Thesis Program UCLA School of Medicine
• 1995
  Upjohn Achievement Award
• 2002
  Travel Award, Junior Investigator, International Society for Differentiation, Lyon, France
• 2002
  Invited Lecturer, European Society for Therapeutic Radiation Oncology, Prague, CZ
• 2003
  Junior Investigator Award, European Society for Therapeutic Radiation Oncology
• 2003
  Basic Science Junior Investigator Award, American Society for Therapeutic Radiation Oncology
• 2005
  Association of American Medical Colleges Early Career Faculty Women's Professional Development Seminar, Santa Fe, NM

• Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, Silver B, Hetelekidis S, Abner A, Harris JR, Schnitt SJ. Outcome at 8 Years After Breast-Conserving Surgery and Radiation Therapy for Invasive Breast Cancer: Influence of Margin Status and Systemic Therapy on Local Recurrence. Journal of Clinical Oncology 18:1668-1675, 2000.
• Park CC, Hartmann C, Folkerth R, Loeffler JS, Wen PY, Fine HA, Black PM, Shafman T, Louis DN. J Systemic Metastasis in Glioblastoma May Represent the Emergence of Neoplastic Subclones. Journal of Neuropathology and Experimental Neurology. 2000 Dec;59(12):1044-50.
• Park CC, Bissell MJ and Barcellos-Hoff MH, The Influence of the Microenvironment on the Malignant Phenotype. Molecular Medicine Today, 2000 Aug;6(8):324-9.
• Park CC, Henshall-Powell RL, Erickson AC, Talhouk R, Parvin B, Bissell MJ, Barcellos-Hoff MH. Ionizing Radiation Induces Heritable Disruption of Epithelial Interactions. Proceedings of the National Academy of Sciences U S A. 2003 Sep 16;100(19):10728-33.
• Park CC, Seid P, Morita E, Iwanaga K, Weinberg V, Quivey J, Hwang ES, Esserman LJ, Leong S. Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment. Breast J. 2005 Jan-Feb;11(1):29-33.
• Coleman J, Park CC, Villarreal-Barajas JE, Petti P, Faddegon B. Monte Carlo Calculation of Heart and Lung Dose for the Electron Boost in the Treatment of Breast Cancer. Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):621-8.
• Barcellos-Hoff MH, Park C, Wright EG, Radiation Therapy and the Microenvironment -- Tumorigenesis and Radiation Therapy. Nature Reviews Cancer 5, 867-875 (2005)
• Park CC, Zhang HZ, Baehner F, Gray, JW, Pallavicini M, Bissell MJ. Disrupting 1 integrin signaling inhibits growth, induces apoptosis, and distinguishes malignant from normal phenotype in 3D cultures and in vivo. Cancer Res 2006; 66: (3). February 1, 2006. Ranked Top Ten by Faculty of 1000 Biologists
• Yao ES, Lee B, Chen YY, Moore D, Park CC. High 1 integrin expression is associated with decreased survival in breast cancer. Cancer Res 2007; 67: (2). January 15, 2007.
• Chang H, Park C, and Parvin B. Quantitative Representation of Three-dimensional Cell Culture Models. 2007 IEEE International Symposium on Biomedical Imaging, February 2007.
• Park CC and Cordes N. 1 integrin as a molecular therapeutic target. Int J Radiat Biol. 2007 Nov-Dec;83(11-12):753-60.
• Park CC, Rembert JR, Chew K, Moore DM, Kerlikowske K. High mammographic breast density and obesity are associated with increased local recurrence following lumpectomy and radiation therapy for invasive breast cancer. Int J Radiat Oncol Biol Phys. 2008 Aug 7.
• Rembert J, Klifa C, Lu Y, Gibbs J, Hylton N, Park CC, Stromal Enhancement by MRI is Associated with Response to Neoadjuvant Chemotherapy. AJR 2008 Jun;190(6):1630-6.
• Park CC, Zhang HJ, Yao ES, Kim S, Park CJ, Bissell MJ. Inhibition of 1 integrin enhances breast cancer radiotherapy. Cancer Res. 2008 Jun 1;68(11):4398-405.
• Descovich M, Fowble B, Bevan A, Schechter N, Park CC, and Xia P. Comparison between Direct Aperture Optimized IMRT and Forward Planning IMRT for Whole Breast Irradiation. In press, IJROBP May 2008.
• DeWoskin D, Climent J, Cruz-White I, Vazquez M, Park CC, Arsuaga J. Applications of Computational Homology to Prediction of Treatment Response in Breast Cancer Patients Proceedings of Topology and Its Applications, June 2008.